Andrew Kelly

Corporate Officer/Principal presso The University of Newcastle

Consumer Services

Commercial Services

Profilo

Andrew Kelly is currently working as a Principal at The University of Newcastle.
Previously, he worked as a Chief Scientific Officer at Biotecnol-Serviços e Desenvolvimento SA. He holds a doctorate degree from King's College London.

Posizioni attive di Andrew Kelly

Società	Posizione	Inizio
The University of Newcastle	Corporate Officer/Principal	-

Tutte le posizioni attive di Andrew Kelly

Precedenti posizioni note di Andrew Kelly

Società	Posizione	Fine
Biotecnol-Serviços e Desenvolvimento SA Biotecnol-Serviços e Desenvolvimento SA Miscellaneous Commercial ServicesCommercial Services Biotecnol-Serviços e Desenvolvimento SA engages in the discovery, engineering, and development of multifunctional antibody molecules, directed to key therapeutic targets. The firm operates as a biopharmaceutical company working in the field of immuno-oncology. It uses Tribody technology to develop a pipeline of in-house discovered products in selected oncology indications. The company was founded in 1997 and is headquartered in Oeiras, Portugal.	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di Andrew Kelly

Formazione di Andrew Kelly

King's College London

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Andrew Kelly

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
Biotecnol-Serviços e Desenvolvimento SA Biotecnol-Serviços e Desenvolvimento SA Miscellaneous Commercial ServicesCommercial Services Biotecnol-Serviços e Desenvolvimento SA engages in the discovery, engineering, and development of multifunctional antibody molecules, directed to key therapeutic targets. The firm operates as a biopharmaceutical company working in the field of immuno-oncology. It uses Tribody technology to develop a pipeline of in-house discovered products in selected oncology indications. The company was founded in 1997 and is headquartered in Oeiras, Portugal.	Commercial Services